Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-11-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 14633736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands.

  2003cited by this paper
• National Comprehensive Cancer Network guidelines for the management of prostate cancer.

  2003cited by this paper
• Androgen receptor as a target in androgen-independent prostate cancer.

  2002cited by this paper
• Evaluation of ligand-dependent changes in AR structure using peptide probes.

  2002cited by this paper
• The program of androgen-responsive genes in neoplastic prostate epithelium

  2002cited by this paper
• Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.

  2002cited by this paper
• Minireview: Nuclear Receptor Coactivators-An Update.

  2002cited by this paper
• Identification and characterization of novel estrogen receptor-beta-sparing antiprogestins.

  2002cited by this paper
• The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.

  2002cited by this paper
• The FXXLF Motif Mediates Androgen Receptor-specific Interactions with Coregulators*

  2002influential reference
• The role of androgens and the androgen receptor in prostate cancer.

  2002cited by this paper
• Identification and Characterization of Novel Estrogen Receptor-β-Sparing Antiprogestins.

  2002cited by this paper
• Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2*

  2001cited by this paper
• Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer.

  2001cited by this paper
• Capitalizing on the Complexities of Estrogen Receptor Pharmacology in the Quest for the Perfect SERM

  2001cited by this paper
• Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

  2000cited by this paper
• Prostate cancer and the androgen receptor: strategies for the development of novel therapeutics.

  2000cited by this paper
• FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor*

  2000influential reference
• Hormone therapy for patients with prostate carcinoma

  2000cited by this paper
• Androgen receptors in prostate and skeletal muscle.

  2000cited by this paper
• Complete androgen blockade for prostate cancer: what went wrong?

  2000cited by this paper
• One and the same androgen for all? Towards designer androgens.

  1999cited by this paper
• Nuclear receptor coregulators: cellular and molecular biology.

  1999cited by this paper
• Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.

  1999cited by this paper
• Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium.

  1999cited by this paper
• The Anti‐Androgen Hydroxyflutamide and Androgens Inhibit Interleukin‐6 Production by an Androgen‐Responsive Human Osteoblastic Cell Line

  1999cited by this paper
• Rapid signalling by androgen receptor in prostate cancer cells

  1999cited by this paper
• Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).

  1998cited by this paper
• Endocrine aspects of ageing in the male.

  1998cited by this paper
• Functional Interactions of the AF2 Activation Domain Core Region of the Human Androgen Receptor with the Amino-Terminal Domain and with the Transcriptional Coactivator TIF 2 ( Transcriptional Intermediary Factor 2 )

  1998cited by this paper
• Intermolecular NH2-/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity*

  1998cited by this paper
• Prostate-specific antigen and early detection of prostate cancer.

  1997cited by this paper
• Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor.

  1997cited by this paper
• Transcriptional Repression of the α-Subunit Gene by Androgen Receptor Occurs Independently of DNA Binding but Requires the DNA-Binding and Ligand-Binding Domains of the Receptor

  1997cited by this paper
• Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells.

  1997cited by this paper
• Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization.

  1996cited by this paper
• Androgens in men--uses and abuses.

  1996cited by this paper
• Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells.

  1996cited by this paper
• The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.

  1996cited by this paper
• Androgen Receptor-Ets Protein Interaction Is a Novel Mechanism for Steroid Hormone-mediated Down-modulation of Matrix Metalloproteinase Expression*

  1996cited by this paper
• Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer (*)

  1995cited by this paper
• Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.

  1995cited by this paper
• Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element.

  1995cited by this paper
• Identification of a New Subclass of Alu DNA Repeats Which Can Function as Estrogen Receptor-dependent Transcriptional Enhancers (*)

  1995cited by this paper
• History and perspectives of antiprogestins from the chemist's point of view.

  1994cited by this paper
• Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene.

  1993cited by this paper
• The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens.

  1992cited by this paper
• Challenges in the management of prostate cancer.

  1992cited by this paper
• Detection of hematogenous micrometastasis in patients with prostate cancer.

  1992cited by this paper
• Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones.

  1991cited by this paper
• Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

  1988cited by this paper

• High-Affinity Probes for Androgen Receptor Imaging: From Cells and In Silico Modeling to Whole-Body Fluorescent Applications

  2025cites this paper
• Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells

  2024cites this paper
• Blocking the dimerization of polyglutamine-expanded androgen receptor protects cells from DHT-induced toxicity by increasing AR turnover

  2024cites this paper
• Targeting the androgen receptor signaling pathway in advanced prostate cancer.

  2022cites this paper
• Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.

  2021cites this paper
• Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.

  2021cites this paper
• Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review.

  2020cites this paper
• Androgen receptor variant 12 promotes migration and invasion by regulating MYLK in gastric cancer

  2019cites this paper
• Identification of Androgen Receptor Modulators in a Prostate Cancer Cell Line Microarray Compendium

  2018cites this paper
• Advancements in Non-steroidal Antiandrogens as Potential Therapeutic Agents for the Treatment of Prostate Cancer.

  2016cites this paper
• IDENTIFICATION OF NOVEL 5-STYRYL-1,2,4-OXADIAZOLE/TRIAZOLE DERIVATIVES AS THE POTENTIAL ANTI-ANDROGENS THROUGH MOLECULAR DOCKING STUDY

  2016cites this paper
• Elucidation of AR impact on the paternally expressed Gene 10 (PEG10) in Enzalutamide-resistant prostate cancer

  2016cites this paper
• Androgen receptor: structure, role in prostate cancer and drug discovery

  2014cites this paper
• Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G1 to S Phase

  2013cites this paper
• Testosterone: The state-of-the-art in the development of selective androgen receptor modulators

  2012cites this paper
• Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300‐dependent acetylation of androgen receptor

  2011cites this paper
• Androgen receptor as a therapeutic target.

  2010cites this paper
• Peptide antagonist of the androgen receptor.

  2010cites this paper
• An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy*

  2010cites this paper
• Androgen Effects on the Skeletal Muscle

  2010cites this paper
• Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.

  2009cites this paper
• Selective androgen receptor modulators as function promoting therapies

  2009cites this paper
• The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.

  2009cites this paper
• Coregulators and the Regulation of Androgen Receptor Action in Prostate Cancer

  2009cites this paper
• Functional Motifs of the Androgen Receptor

  2009cites this paper
• Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.

  2008cites this paper
• RNA Editing of Androgen Receptor Gene Transcripts in Prostate Cancer Cells*

  2008cites this paper
• Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells

  2007cites this paper
• Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).

  2007influential citation
• Novel Approaches to Androgen Receptor Blockade

  2006cites this paper
• The androgen receptor pathway is by‐passed in prostate cancer cells generated after prolonged treatment with bicalutamide

  2006cites this paper
• The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.

  2006cites this paper
• Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery

  2006cites this paper
• Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging

  2006cites this paper
• Hormonal Control of Androgen Receptor Function through SIRT1

  2006cites this paper
• Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators.

  2006cites this paper
• Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.

  2005cites this paper
• Chemistry and structural biology of androgen receptor.

  2005cites this paper
• Development of peptide antagonists for the androgen receptor using combinatorial peptide phage display.

  2005cites this paper
• Androgen receptor-cofactor interactions as targets for new drug discovery.

  2005cites this paper
• Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.

  2004cites this paper
• Award Number: W81XWH-06-1-0444 TITLE: The Role of Estrogen-Related Receptor Alpha in Steroidogenesis in the Breast PRINCIPAL INVESTIGATOR:

  year unknowncites this paper